Your session is about to expire
← Back to Search
Hybrid Cardiac Rehabilitation for Cardiovascular Disease (iATTEND Trial)
iATTEND Trial Summary
This trial will assess the efficacy of an innovative approach to cardiac rehabilitation that combines both center-based and remote- or home-based CR sessions.
iATTEND Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.iATTEND Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a heart device on the left side, need continuous support medication for your heart, or are undergoing hemodialysis.You have chest pain at rest or with light physical activity.You have advanced cancer, high risk of falling, severe memory problems, or other serious conditions that make it hard for you to take part in the study.You are expected to live for less than 12 months.You have had a serious heart problem in the past 6 months or have been diagnosed with certain heart conditions.You are between 18 and 85 years old.You will take a test to see how well you can remember and think. If you score below 3, you may not be able to join the study.You have a serious heart rhythm problem, unless it has been treated with a device like an implantable cardiac defibrillator.You are planning to have a major heart procedure or be hospitalized in the next 6 months.Your risk for falling will be checked by how long it takes you to stand up and sit down 5 times. If it takes you longer than 15 seconds, you may be at higher risk for falling.
- Group 1: Hybrid Cardiac Rehabilitation (HYCR)
- Group 2: Center Based cardiac Rehabilitation (CBCR)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are persons aged 80 or younger qualified to participate in this investigation?
"Participants of this trial must be between 18 and 85 years old."
Who qualifies to join this research endeavor?
"In order to be enrolled in the trial, applicants must have a diagnosis of angina pectoris and fall within the ages of 18-85. The recruitment goal is 270 patients."
What is the current rate of enrollment for this clinical investigation?
"Affirmative. On clinicaltrials.gov, the information regarding this trial signifies that it is currently enrolling patients. This medical experiment was initially advertised on March 1st 2019 and then updated for the last time on August 26th 2021. The research necessitates 270 participants to be recruited from one site."
Is the intake of participants open for this trial?
"Confirmed. Patients are being sought for this clinical study, which was first announced on the 1st of March 2019 and underwent its most recent update on August 26th 2021."
Share this study with friends
Copy Link
Messenger